Compare EIKN & STK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EIKN | STK |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 731.6M | 688.8M |
| IPO Year | N/A | 2009 |
| Metric | EIKN | STK |
|---|---|---|
| Price | $11.52 | $45.45 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $25.60 | N/A |
| AVG Volume (30 Days) | ★ 352.2K | 44.1K |
| Earning Date | 03-30-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.58 | $25.04 |
| 52 Week High | $16.50 | $45.49 |
| Indicator | EIKN | STK |
|---|---|---|
| Relative Strength Index (RSI) | 53.00 | 74.42 |
| Support Level | $10.82 | $38.21 |
| Resistance Level | $13.75 | N/A |
| Average True Range (ATR) | 0.89 | 1.30 |
| MACD | 0.30 | 0.77 |
| Stochastic Oscillator | 95.27 | 91.45 |
Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services.